|
Market Closed -
Nasdaq
00:00:00 06/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.220 USD | -3.90% |
|
-6.72% | +37.89% |
Company Valuation: MacroGenics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 983.2 | 412.5 | 596.7 | 204 | 101.8 | 142.4 | - | - |
| Change | - | -58.04% | 44.66% | -65.82% | -50.07% | 39.79% | - | - |
| Enterprise Value (EV) | 983.2 | 412.5 | 366.9 | 204 | 101.8 | 142.4 | 142.4 | 142.4 |
| Change | - | -58.04% | -11.05% | -44.41% | -50.07% | 39.79% | 0% | 0% |
| P/E | -4.76x | -3.44x | -64.1x | -3.04x | -1.36x | -1.43x | -1.36x | -1.09x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.1x | 0.7x | -0x | -0.1x | -0x | -0.26x | -0x |
| Capitalization / Revenue | 12.7x | 2.71x | 10.2x | 1.36x | 0.68x | 1.32x | 1.57x | 1.58x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.32x | 1.57x | 1.58x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.54x | -1.09x | -0.85x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -1.69x | -1.02x | -1.09x |
| FCF Yield | -15.3% | -22% | -13.4% | -35.3% | -81.5% | -59% | -97.7% | -92% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.37 | -1.95 | -0.15 | -1.07 | -1.18 | -1.558 | -1.64 | -2.049 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 77.45 | 151.9 | 58.75 | 150 | 149.5 | 108.2 | 90.61 | 90.12 |
| EBITDA | -191.5 | -109.6 | -158.6 | - | - | - | - | - |
| EBIT 1 | -202.8 | -121.4 | -168.2 | -110.6 | -72.84 | -92.47 | -130.9 | -167.6 |
| Net income 1 | -202.1 | -119.8 | -9.058 | -66.97 | -74.62 | -88.7 | -138.1 | -180.5 |
| Net Debt | - | - | -229.8 | - | - | - | - | - |
| Reference price 2 | 16.050 | 6.710 | 9.620 | 3.250 | 1.610 | 2.235 | 2.235 | 2.235 |
| Nbr of stocks (in thousands) | 61,258 | 61,475 | 62,029 | 62,763 | 63,259 | 63,700 | - | - |
| Announcement Date | 2/24/22 A | 3/15/23 A | 3/7/24 A | 3/20/25 A | 3/9/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48x | - | - | - | 147M | |
| 17.65x | 6.7x | 12.84x | 1.69% | 66.87B | |
| 38.55x | 6.82x | 20.37x | 0.84% | 56.55B | |
| 30.7x | 8.25x | 27.69x | 0.05% | 57.2B | |
| 34.43x | 3.28x | 14.15x | -.--% | 43.47B | |
| -20.73x | 201.32x | -22.15x | -.--% | 42.8B | |
| 49.83x | 5.75x | 31.5x | -.--% | 42.95B | |
| 43.47x | 7.75x | 25.96x | -.--% | 32.11B | |
| 34.02x | 8.4x | 21.89x | 0.39% | 34.01B | |
| -68.94x | 12.7x | -71.03x | -.--% | 24.13B | |
| Average | 15.75x | 29.00x | 6.80x | 0.33% | 40.02B | |
| Weighted average by Cap. | 21.87x | 27.88x | 11.19x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MGNX Stock
- Valuation MacroGenics, Inc.
Select your edition
All financial news and data tailored to specific country editions
